| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:737518 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CRYAB mRNA | CTD | PMID:22079256 |
| (S)-nicotine | decreases expression | ISO | RGD:10400 | 6480464 | Nicotine results in decreased expression of CRYAB mRNA | CTD | PMID:21955143 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:10400 | 6480464 | Ethinyl Estradiol affects the expression of CRYAB mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of CRYAB mRNA | CTD | PMID:17557909 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:10400 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CRYAB mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:10400 | 6480464 | Ethinyl Estradiol results in increased expression of CRYAB mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | multiple interactions | ISO | RGD:737518 | 6480464 | [Progesterone co-treated with Estradiol] results in increased expression of CRYAB mRNA | CTD | PMID:17404688 |
| 17beta-estradiol | increases expression | ISO | RGD:737518 | 6480464 | Estradiol results in increased expression of CRYAB mRNA | CTD | PMID:23373633 |
| 1H-pyrazole | increases expression | ISO | RGD:10400 | 6480464 | pyrazole results in increased expression of CRYAB mRNA | CTD | PMID:17945193 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10400 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CRYAB mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CRYAB mRNA | CTD | PMID:20959002 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10400 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein results in increased expression of CRYAB mRNA] | CTD | PMID:21494593 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:10400 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CRYAB mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:10400 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CRYAB mRNA | CTD | PMID:19770486 |
| 2,6-dichloroindophenol | multiple interactions | ISO | RGD:737518 | 6480464 | [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of CRYAB mRNA | CTD | PMID:21034357 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of CRYAB mRNA | CTD | PMID:21346803 |
| 2-acetamidofluorene | increases expression | EXP | | 6480464 | 2-Acetylaminofluorene results in increased expression of CRYAB mRNA | CTD | PMID:17070881 |
| 2-nitrofluorene | increases expression | EXP | | 6480464 | 2-nitrofluorene results in increased expression of CRYAB mRNA | CTD | PMID:14600272 |
| 2-nitropropane | increases expression | EXP | | 6480464 | 2-nitropropane results in increased expression of CRYAB mRNA | CTD | PMID:17070881 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | EXP | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CRYAB mRNA | CTD | PMID:14600272 |
| 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:737518 | 6480464 | Fenretinide results in increased expression of CRYAB mRNA | CTD | PMID:16671099 |
| 4-nitro-1,2-phenylenediamine | decreases expression | EXP | | 6480464 | 1,2-diamino-4-nitrobenzene results in decreased expression of CRYAB mRNA | CTD | PMID:17070881 |
| 4-nitroquinoline N-oxide | multiple interactions | ISO | RGD:10400 | 6480464 | [4-Nitroquinoline-1-oxide co-treated with Arecoline] results in increased expression of CRYAB protein | CTD | PMID:19840781 |
| 5-azacytidine | increases expression | EXP | | 6480464 | Azacitidine results in increased expression of CRYAB protein | CTD | PMID:17105402 |
| 7H-xanthine | multiple interactions | EXP | | 6480464 | [Xanthine co-treated with XDH protein] results in decreased expression of CRYAB protein | CTD | PMID:19464573 |
| 9H-xanthine | multiple interactions | EXP | | 6480464 | [Xanthine co-treated with XDH protein] results in decreased expression of CRYAB protein | CTD | PMID:19464573 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of CRYAB mRNA | CTD | PMID:14600272 |
| aflatoxin B1 | decreases expression | ISO | RGD:10400 | 6480464 | Aflatoxin B1 results in decreased expression of CRYAB mRNA | CTD | PMID:19770486 |
| aflatoxin B1 | affects expression | ISO | RGD:737518 | 6480464 | Aflatoxin B1 affects the expression of CRYAB protein | CTD | PMID:20106945 |
| all-trans-retinoic acid | increases expression | ISO | RGD:737518 | 6480464 | Tretinoin results in increased expression of CRYAB mRNA | CTD | PMID:16249480 |
| all-trans-retinoic acid | increases expression | ISO | RGD:10400 | 6480464 | Tretinoin results in increased expression of CRYAB mRNA | CTD | PMID:20117194 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of CRYAB mRNA | CTD | PMID:16483693 |
| arsenic atom | affects expression | EXP | | 6480464 | Arsenic affects the expression of CRYAB mRNA | CTD | PMID:18315880 |
| arsenite(3-) | increases expression | ISO | RGD:10400 | 6480464 | arsenite results in increased expression of CRYAB protein | CTD | PMID:9764755 |
| arsenite(3-) | multiple interactions | EXP | | 6480464 | Bucladesine inhibits the reaction [arsenite results in increased expression of CRYAB protein]; more ... | CTD | PMID:8769853 |
| arsenite(3-) | increases expression | EXP | | 6480464 | arsenite results in increased expression of CRYAB protein | CTD | PMID:15175009 more ... |
| arsenite(3-) | increases expression | EXP | | 6480464 | arsenite results in increased expression of CRYAB mRNA | CTD | PMID:8769853 PMID:9066782 |
| arsenite(3-) | multiple interactions | EXP | | 6480464 | 9-deoxy-delta-9-prostaglandin D2 promotes the reaction [arsenite results in increased expression of CRYAB mRNA]; more ... | CTD | PMID:9066782 |
| arsenite(3-) | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [arsenite results in increased expression of CRYAB protein]; more ... | CTD | PMID:15175009 |
| arsenite(3-) | increases expression | EXP | | 6480464 | arsenite results in increased expression of CRYAB protein | CTD | PMID:15175009 more ... |
| arsenite(3-) | increases expression | EXP | | 6480464 | arsenite results in increased expression of CRYAB mRNA | CTD | PMID:9066782 |
| arsenite(3-) | decreases response to substance | ISO | RGD:10400 | 6480464 | CRYAB protein results in decreased susceptibility to arsenite | CTD | PMID:15590893 |
| arsenite(3-) | increases expression | ISO | RGD:10400 | 6480464 | arsenite results in increased expression of CRYAB protein | CTD | PMID:15590893 PMID:9764755 |
| arsenite(3-) | multiple interactions | ISO | RGD:10400 | 6480464 | [arsenite co-treated with Mercury] promotes the reaction [Cadmium results in increased expression of CRYAB protein]; more ... | CTD | PMID:15590893 |
| arsenite(3-) | increases expression | EXP | | 6480464 | arsenite results in increased expression of CRYAB protein | CTD | PMID:9764755 |
| arsenite(3-) | multiple interactions | EXP | | 6480464 | [Curcumin co-treated with arsenite] results in increased expression of CRYAB mRNA; more ... | CTD | PMID:9764755 |
| arsenite(3-) | multiple interactions | ISO | RGD:10400 | 6480464 | Curcumin promotes the reaction [arsenite results in increased expression of CRYAB protein] | CTD | PMID:9764755 |
| benzo[a]pyrene | increases expression | ISO | RGD:737518 | 6480464 | Benzo(a)pyrene results in increased expression of CRYAB mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | decreases expression | ISO | RGD:10400 | 6480464 | Benzo(a)pyrene results in decreased expression of CRYAB mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10400 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of CRYAB mRNA | CTD | PMID:21715664 |
| bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CRYAB mRNA | CTD | PMID:18180321 |
| bucladesine | multiple interactions | EXP | | 6480464 | Bucladesine inhibits the reaction [arsenite results in increased expression of CRYAB protein] | CTD | PMID:8769853 |
| cadmium atom | multiple interactions | ISO | RGD:10400 | 6480464 | [arsenite co-treated with Cadmium] promotes the reaction [Mercury results in increased expression of CRYAB protein]; more ... | CTD | PMID:15590893 |
| cadmium atom | increases expression | ISO | RGD:10400 | 6480464 | Cadmium results in increased expression of CRYAB protein | CTD | PMID:15590893 |
| cadmium atom | decreases response to substance | ISO | RGD:10400 | 6480464 | CRYAB protein results in decreased susceptibility to Cadmium | CTD | PMID:15590893 |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | [Curcumin co-treated with Cadmium Chloride] results in increased expression of CRYAB protein | CTD | PMID:9764755 |
| cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of CRYAB mRNA | CTD | PMID:19010381 PMID:22110744 |
| cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of CRYAB mRNA | CTD | PMID:22110744 PMID:19010381 |
| calcitriol | increases expression | ISO | RGD:737518 | 6480464 | Calcitriol results in increased expression of CRYAB mRNA | CTD | PMID:21592394 |
| calcitriol | multiple interactions | ISO | RGD:737518 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of CRYAB mRNA | CTD | PMID:21592394 |
| celecoxib | multiple interactions | EXP | | 6480464 | celecoxib promotes the reaction [Carbon Tetrachloride results in increased expression of CRYAB mRNA] | CTD | PMID:16420518 |
| chlorpyrifos | increases expression | ISO | RGD:10400 | 6480464 | Chlorpyrifos results in increased expression of CRYAB mRNA | CTD | PMID:20350560 |
| cisplatin | increases expression | ISO | RGD:10400 | 6480464 | Cisplatin results in increased expression of CRYAB mRNA | CTD | PMID:21151649 |
| cocaine | decreases expression | ISO | RGD:737518 | 6480464 | Cocaine results in decreased expression of CRYAB mRNA | CTD | PMID:15009677 |
| copper atom | increases expression | ISO | RGD:737518 | 6480464 | Copper results in increased expression of CRYAB mRNA | CTD | PMID:19747488 |
| copper atom | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of CRYAB protein | CTD | PMID:18993053 |
| copper atom | multiple interactions | ISO | RGD:737518 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of CRYAB mRNA | CTD | PMID:20971185 |
| copper(0) | increases expression | ISO | RGD:737518 | 6480464 | Copper results in increased expression of CRYAB mRNA | CTD | PMID:19747488 |
| copper(0) | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of CRYAB protein | CTD | PMID:18993053 |
| copper(0) | multiple interactions | ISO | RGD:737518 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of CRYAB mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | increases expression | ISO | RGD:737518 | 6480464 | Copper Sulfate results in increased expression of CRYAB mRNA | CTD | PMID:19549813 |
| copper(II) chloride | increases expression | ISO | RGD:737518 | 6480464 | cupric chloride results in increased expression of CRYAB mRNA | CTD | PMID:17211630 |
| coumarin | decreases expression | EXP | | 6480464 | coumarin results in decreased expression of CRYAB mRNA | CTD | PMID:18480146 |
| curcumin | multiple interactions | ISO | RGD:10400 | 6480464 | Curcumin promotes the reaction [arsenite results in increased expression of CRYAB protein] | CTD | PMID:9764755 |
| curcumin | multiple interactions | EXP | | 6480464 | [Curcumin co-treated with arsenite] results in increased expression of CRYAB mRNA; more ... | CTD | PMID:9764755 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of CRYAB protein | CTD | PMID:19540300 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of CRYAB protein | CTD | PMID:21073006 |
| cyclosporin A | affects localization | EXP | | 6480464 | Cyclosporine affects the localization of CRYAB protein | CTD | PMID:19540300 |
| cytarabine | decreases expression | ISO | RGD:737518 | 6480464 | Cytarabine results in decreased expression of CRYAB mRNA | CTD | PMID:21198554 |
| dasatinib (anhydrous) | increases expression | ISO | RGD:737518 | 6480464 | dasatinib results in increased expression of CRYAB mRNA | CTD | PMID:20579391 |
| Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:10400 | 6480464 | Tetrahydrocannabinol results in increased expression of CRYAB mRNA | CTD | PMID:21955143 |
| dexamethasone | increases expression | ISO | RGD:737518 | 6480464 | Dexamethasone results in increased expression of CRYAB mRNA | CTD | PMID:19064852 |
| dexamethasone | multiple interactions | ISO | RGD:737518 | 6480464 | Ginkgo biloba extract 761 promotes the reaction [Dexamethasone results in increased expression of CRYAB mRNA] | CTD | PMID:19064852 |
| diazoxide | multiple interactions | EXP | | 6480464 | Isoproterenol inhibits the reaction [arsenite results in increased expression of CRYAB protein] | CTD | PMID:8769853 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of CRYAB mRNA | CTD | PMID:21266533 |
| diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of CRYAB mRNA | CTD | PMID:21551480 |
| doxorubicin | decreases response to substance | ISO | RGD:737518 | 6480464 | CRYAB mRNA results in decreased susceptibility to Doxorubicin | CTD | PMID:16322897 |
| ethanol | decreases expression | EXP | | 6480464 | Ethanol results in decreased expression of CRYAB mRNA | CTD | PMID:17920746 |
| ethanol | increases expression | ISO | RGD:10400 | 6480464 | Ethanol results in increased expression of CRYAB mRNA | CTD | PMID:21955143 |
| formaldehyde | increases expression | ISO | RGD:737518 | 6480464 | Formaldehyde results in increased expression of CRYAB mRNA | CTD | PMID:20655997 |
| glutathione | multiple interactions | EXP | | 6480464 | Glutathione inhibits the reaction [arsenite results in increased expression of CRYAB protein] | CTD | PMID:15175009 |
| indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of CRYAB mRNA | CTD | PMID:21396975 |
| indomethacin | multiple interactions | EXP | | 6480464 | Indomethacin promotes the reaction [sodium arsenite results in increased expression of CRYAB mRNA]; more ... | CTD | PMID:8591993 |
| isoprenaline | multiple interactions | EXP | | 6480464 | Isoproterenol inhibits the reaction [arsenite results in increased expression of CRYAB protein] | CTD | PMID:8769853 |
| ketamine | increases expression | EXP | | 6480464 | Ketamine results in increased expression of CRYAB mRNA | CTD | PMID:20080153 |
| L-ascorbic acid | increases expression | EXP | | 6480464 | Ascorbic Acid results in increased expression of CRYAB mRNA | CTD | PMID:15372504 |
| lead diacetate | increases expression | ISO | RGD:10400 | 6480464 | lead acetate results in increased expression of CRYAB mRNA | CTD | PMID:22609695 |
| lithium atom | decreases expression | EXP | | 6480464 | Lithium results in decreased expression of CRYAB protein | CTD | PMID:18296634 |
| mercury atom | multiple interactions | ISO | RGD:10400 | 6480464 | [arsenite co-treated with Cadmium] promotes the reaction [Mercury results in increased expression of CRYAB protein]; more ... | CTD | PMID:15590893 |
| mercury atom | increases expression | ISO | RGD:10400 | 6480464 | Mercury results in increased expression of CRYAB protein | CTD | PMID:15590893 |
| mercury atom | decreases response to substance | ISO | RGD:10400 | 6480464 | CRYAB protein results in decreased susceptibility to Mercury | CTD | PMID:15590893 |
| mercury(0) | multiple interactions | ISO | RGD:10400 | 6480464 | [arsenite co-treated with Cadmium] promotes the reaction [Mercury results in increased expression of CRYAB protein]; more ... | CTD | PMID:15590893 |
| mercury(0) | increases expression | ISO | RGD:10400 | 6480464 | Mercury results in increased expression of CRYAB protein | CTD | PMID:15590893 |
| mercury(0) | decreases response to substance | ISO | RGD:10400 | 6480464 | CRYAB protein results in decreased susceptibility to Mercury | CTD | PMID:15590893 |
| methanol | increases expression | EXP | | 6480464 | Methanol results in increased expression of CRYAB protein | CTD | PMID:22257634 |
| morphine | decreases expression | ISO | RGD:10400 | 6480464 | Morphine results in decreased expression of CRYAB mRNA | CTD | PMID:21955143 |
| morphine | increases expression | EXP | | 6480464 | Morphine results in increased expression of CRYAB protein | CTD | PMID:23056601 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [arsenite results in increased expression of CRYAB protein] | CTD | PMID:15175009 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CRYAB mRNA | CTD | PMID:18164116 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of CRYAB mRNA | CTD | PMID:19638242 |
| N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of CRYAB mRNA | CTD | PMID:14600272 |
| nickel dichloride | affects expression | EXP | | 6480464 | nickel chloride affects the expression of CRYAB mRNA | CTD | PMID:22110744 |
| nordihydroguaiaretic acid | multiple interactions | EXP | | 6480464 | Nordihydroguaiaretic Acid promotes the reaction [sodium arsenite results in increased expression of CRYAB protein]; more ... | CTD | PMID:8591993 |
| ochratoxin A | decreases expression | EXP | | 6480464 | ochratoxin A results in decreased expression of CRYAB mRNA | CTD | PMID:23358140 |
| paracetamol | increases expression | ISO | RGD:737518 | 6480464 | Acetaminophen results in increased expression of CRYAB mRNA | CTD | PMID:21420995 |
| pioglitazone | multiple interactions | ISO | RGD:737518 | 6480464 | [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CRYAB mRNA; more ... | CTD | PMID:20847119 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of CRYAB mRNA | CTD | PMID:19162173 |
| progesterone | multiple interactions | ISO | RGD:737518 | 6480464 | [Progesterone co-treated with Estradiol] results in increased expression of CRYAB mRNA | CTD | PMID:17404688 |
| prostaglandin A1 | multiple interactions | EXP | | 6480464 | prostaglandin A1 promotes the reaction [arsenite results in increased expression of CRYAB mRNA]; more ... | CTD | PMID:9066782 |
| prostaglandin A2 | multiple interactions | EXP | | 6480464 | prostaglandin A2 promotes the reaction [arsenite results in increased expression of CRYAB protein]; more ... | CTD | PMID:9066782 |
| prostaglandin D2 | multiple interactions | EXP | | 6480464 | Prostaglandin D2 promotes the reaction [arsenite results in increased expression of CRYAB protein] | CTD | PMID:9066782 |
| prostaglandin E2 | multiple interactions | EXP | | 6480464 | Dinoprostone promotes the reaction [arsenite results in increased expression of CRYAB protein]; more ... | CTD | PMID:9066782 |
| prostaglandin J2 | multiple interactions | EXP | | 6480464 | 9-deoxy-delta-9-prostaglandin D2 promotes the reaction [arsenite results in increased expression of CRYAB mRNA]; more ... | CTD | PMID:9066782 |
| rosiglitazone | multiple interactions | ISO | RGD:737518 | 6480464 | [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CRYAB mRNA | CTD | PMID:20847119 |
| rosiglitazone | affects expression | ISO | RGD:737518 | 6480464 | rosiglitazone affects the expression of CRYAB protein; more ... | CTD | PMID:19556978 |
| scopolamine | increases expression | EXP | | 6480464 | Scopolamine Hydrobromide results in increased expression of CRYAB mRNA | CTD | PMID:17540011 |
| tamoxifen | affects expression | ISO | RGD:10400 | 6480464 | Tamoxifen affects the expression of CRYAB mRNA | CTD | PMID:17555576 |
| tert-butyl hydroperoxide | multiple interactions | ISO | RGD:737518 | 6480464 | [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CRYAB mRNA; more ... | CTD | PMID:20847119 |
| tert-butyl hydroperoxide | decreases expression | ISO | RGD:737518 | 6480464 | tert-Butylhydroperoxide results in decreased expression of CRYAB mRNA | CTD | PMID:15336504 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:737518 | 6480464 | tert-Butylhydroperoxide results in increased expression of CRYAB mRNA | CTD | PMID:20847119 |
| testosterone | multiple interactions | ISO | RGD:737518 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of CRYAB mRNA | CTD | PMID:21592394 |
| testosterone | increases expression | ISO | RGD:737518 | 6480464 | Testosterone results in increased expression of CRYAB mRNA | CTD | PMID:21592394 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of CRYAB mRNA | CTD | PMID:16420518 PMID:15728706 |
| tetrachloromethane | increases expression | ISO | RGD:737518 | 6480464 | Carbon Tetrachloride results in increased expression of CRYAB mRNA | CTD | PMID:16815347 PMID:18207697 |
| tetrachloromethane | multiple interactions | EXP | | 6480464 | celecoxib promotes the reaction [Carbon Tetrachloride results in increased expression of CRYAB mRNA] | CTD | PMID:16420518 |
| tetrachloromethane | increases expression | ISO | RGD:737518 | 6480464 | Carbon Tetrachloride results in increased expression of CRYAB mRNA | CTD | PMID:18207697 PMID:16815347 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of CRYAB mRNA | CTD | PMID:15728706 PMID:16420518 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of CRYAB protein | CTD | PMID:15728706 |
| thimerosal | increases expression | ISO | RGD:737518 | 6480464 | Thimerosal results in increased expression of CRYAB mRNA | CTD | PMID:16870260 |
| titanium dioxide | increases expression | ISO | RGD:10400 | 6480464 | titanium dioxide results in increased expression of CRYAB mRNA | CTD | PMID:23409001 |
| toluene | decreases expression | EXP | | 6480464 | Toluene results in decreased expression of CRYAB mRNA | CTD | PMID:22166486 |
| toluene | increases expression | EXP | | 6480464 | Toluene results in increased expression of CRYAB mRNA | CTD | PMID:22166486 |
| troglitazone | multiple interactions | ISO | RGD:737518 | 6480464 | [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CRYAB mRNA; more ... | CTD | PMID:20847119 |
| troglitazone | increases expression | ISO | RGD:737518 | 6480464 | troglitazone results in increased expression of CRYAB mRNA | CTD | PMID:19631733 |
| ursodeoxycholic acid | decreases expression | EXP | | 6480464 | Ursodeoxycholic Acid results in decreased expression of CRYAB mRNA | CTD | PMID:15885361 |
| valproic acid | decreases expression | ISO | RGD:10400 | 6480464 | Valproic Acid results in decreased expression of CRYAB mRNA | CTD | PMID:15799026 |
| zinc atom | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of CRYAB mRNA | CTD | PMID:19111725 |
| zinc(0) | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of CRYAB mRNA | CTD | PMID:19111725 |